RNAi therapies: drugging the undruggable.
Where this comes from
- Record sourced from PubMed, PMID 24920658.
- Also identified by DOI 10.1126/scitranslmed.3008362 and PMC identifier 4154139.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
RNA interference (RNAi) therapy is a rapidly emerging platform for personalized cancer treatment. Recent advances in small interfering RNA delivery and target selection provide unprecedented opportunities for clinical translation. Here, we discuss these advances and present strategies for making RNAi-based therapy a viable part of cancer management.
Medical subject headings
- Genetic Therapy